Daniela Surace

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe

U. Maggiore, K. Budde, L. Rostaing, 2022, Transplant International.

IGNITE: A phase II signal-seeking trial of adavosertib targeting recurrent high-grade, serous ovarian cancer with cyclin E1 overexpression with and without gene amplification.

L. Mileshkin, G. Kichenadasse, M. Bressel, 2022, Journal of Clinical Oncology.

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide.

U. Grohmann, M. L. Belladonna, P. Puccetti, 1998, Critical reviews in immunology.